-
公开(公告)号:EP3668852A1
公开(公告)日:2020-06-24
申请号:EP18769909.5
申请日:2018-08-17
申请人: The Regents of the University of California , The Board of Trustees of the Leland Stanford Junior University , Friedrich-Alexander-Universität Erlangen-Nürnberg
发明人: SHOICHET, Brian, K. , LEVIT, Anat , MANGLIK, Aashish , KOBILKA, Brian , GMEINER, Peter , HÜBNER, Harald , DENGLER, Daniela, Gisela
IPC分类号: C07D333/20 , A61K31/381 , C07C275/06 , C07C225/00 , C07C233/00 , A61P25/24 , A61P25/04
-
公开(公告)号:EP3565543A1
公开(公告)日:2019-11-13
申请号:EP18736501.0
申请日:2018-01-05
申请人: The Regents of the University of California , Friedrich-Alexander-Universität Erlangen-Nürnberg , The Board of Trustees of the Leland Stanford Junior University , University Of North Carlirona, Chapel Hill
-
公开(公告)号:EP3319444A1
公开(公告)日:2018-05-16
申请号:EP16821843.6
申请日:2016-06-30
申请人: The Regents of the University of California , Friedrich-Alexander-Universität Erlangen-Nürnberg , The Board of Trustees of the Leland Stanford Junior University , The University Of North Carolina At Chapel Hill
发明人: ROTH, Bryan, L. , DENGLER, Daniela, Gisela , SHOICHET, Brian, K. , LIN, Henry , GMEINER, Peter , MANGLIK, Aashish , KOBILKA, Brian
CPC分类号: C07D401/12 , C07C275/24 , C07C275/26 , C07C2602/08 , C07D207/452 , C07D233/16 , C07D249/04 , C07D295/125 , C07D333/16 , C07D333/20 , C07D333/58 , C07D409/12 , C07D471/04 , C07D495/04 , C07D498/18
摘要: Described herein, inter alia, are compositions and methods for modulating mu opioid receptor activity.
-
公开(公告)号:EP4426287A1
公开(公告)日:2024-09-11
申请号:EP22891077.4
申请日:2022-11-04
申请人: The Regents of the University of California , Friedrich-Alexander-Universität Erlangen-Nürnberg , Chinese University of Hong Kong, Shenzhen
发明人: SHOICHET, Brian, K. , FINK, Elissa, A. , BASBAUM, Allan, J. , BRAZ, Joao, M. , GMEINER, Peter , HUBNER, Harald , SEEMANN, Philipp , PFEIFFER, Tara , DU, Yang , XU, Jun
IPC分类号: A61K31/33 , A61K31/395 , A61K31/40
CPC分类号: A61K31/4409 , A61K31/4725 , A61K31/4375 , A61K31/4709 , A61K45/06 , A61K31/195 , A61K31/445 , C07D409/12 , C07D401/12 , C07D401/04 , C07D213/74 , C07D213/68 , C07D211/70 , C07D405/04 , C07D471/04 , C07D417/04
-
5.
公开(公告)号:EP3964497A1
公开(公告)日:2022-03-09
申请号:EP20194568.0
申请日:2020-09-04
发明人: GMEINER, Peter , HUEBNER, Harald , HETZER, Florian
IPC分类号: C07C275/24 , C07C275/26 , C07D333/74 , A61P25/36 , A61K31/36
摘要: The present invention relates to a compound of the following formula (I) or (II), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture thereof:
The invention furthermore relates to a pharmaceutical composition comprising the compound having formula (I) or (II) and optionally one or more pharmaceutically acceptable excipient(s) and/or carrier(s), as well as to these compounds for use in the treatment, amelioration or prevention of pain, opioid overdose, addictions, neuropsychiatric disorders, Prader-Willi Syndrome, gastrointestinal disorders, skin disorders, dyspnea, headache and/or temporomandibular joint dysfunction, including methods of treating, ameliorating or preventing pain involving administering to a patient in need thereof an effective amount of the compound having formula (I) or (II).-
公开(公告)号:EP3494114A1
公开(公告)日:2019-06-12
申请号:EP17758056.0
申请日:2017-08-02
IPC分类号: C07D403/14 , C07F5/00 , A61K51/04 , A61P35/00
-
-
-
-
-